Naomi Morrissette
Tubulin and microtubules, tubulin targeting drugs in protozoan parasites, tubulin mutations
Michael McClelland
High-throughput genetics, evolution of Salmonella pathogenesis; bacterial therapy for cancer; cancer genomics and prognostic
Matthew Marsden
My research is primarily focused on HIV cure efforts and involves molecular analysis of latent HIV together with cellular and
Matthew Griffin
Our lab focuses on understanding the molecular mechanisms underlying host-microbiota interactions during cancer progression and treatment.
Thomas Burke
We are developing novel innate immune agonist drugs for cancer therapy. We are investigating tumor microbiomes and microbial-based cancer therapies.
Selma Masri
Research in the Masri lab is aimed at understanding the relationship between disruption of circadian rhythms and tumorigenesis, with a
Barbara Jusiak
My lab combines mammalian synthetic biology and fruit fly (Drosophila) models to study cancer-host interactions and to engineer immune cells